Infliximab-induced acne: a new case and review of published reports.
Steels
Emmanuelle
E
Department of Dermatology, CHU-Brugmann, Brussels, Belgium.
Peretz
Anne
A
Vereecken
Pierre
P
D017486:Acneiform Eruptions / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008297:Male; D008911:Minocycline / Q000627:therapeutic use; D011565:Psoriasis / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D018570:Risk Assessment; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D000069285:Infliximab; D008911:Minocycline